CN101305017B - 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法 - Google Patents

奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法 Download PDF

Info

Publication number
CN101305017B
CN101305017B CN200680029333.0A CN200680029333A CN101305017B CN 101305017 B CN101305017 B CN 101305017B CN 200680029333 A CN200680029333 A CN 200680029333A CN 101305017 B CN101305017 B CN 101305017B
Authority
CN
China
Prior art keywords
peptides
seq
casein
activity
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200680029333.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN101305017A (zh
Inventor
I·雷西奥桑彻茨
A·奎罗斯德尔博斯奎
B·赫南德茨勒德斯马
J·A·戈梅茨鲁茨
M·米古尔卡斯特罗
M·L·阿米戈加里多
I·洛佩茨埃克斯波西托
M·M·拉莫斯冈扎勒茨
A·阿莱克桑德里德阿蒂纳诺
M·康特雷拉斯戈梅茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to CN201310023562.3A priority Critical patent/CN103254278B/zh
Publication of CN101305017A publication Critical patent/CN101305017A/zh
Application granted granted Critical
Publication of CN101305017B publication Critical patent/CN101305017B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200680029333.0A 2005-06-08 2006-06-08 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法 Expired - Fee Related CN101305017B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310023562.3A CN103254278B (zh) 2005-06-08 2006-06-08 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200501373A ES2319475B1 (es) 2005-06-08 2005-06-08 Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
ESP200501373 2005-06-08
PCT/ES2006/070079 WO2006131586A1 (es) 2005-06-08 2006-06-08 Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201310023562.3A Division CN103254278B (zh) 2005-06-08 2006-06-08 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法

Publications (2)

Publication Number Publication Date
CN101305017A CN101305017A (zh) 2008-11-12
CN101305017B true CN101305017B (zh) 2014-08-06

Family

ID=37498152

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200680029333.0A Expired - Fee Related CN101305017B (zh) 2005-06-08 2006-06-08 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法
CN201310023562.3A Expired - Fee Related CN103254278B (zh) 2005-06-08 2006-06-08 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201310023562.3A Expired - Fee Related CN103254278B (zh) 2005-06-08 2006-06-08 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法

Country Status (12)

Country Link
US (1) US8354502B2 (enExample)
EP (2) EP2495250A3 (enExample)
JP (1) JP2008545774A (enExample)
KR (1) KR101343904B1 (enExample)
CN (2) CN101305017B (enExample)
AU (1) AU2006256720A1 (enExample)
BR (1) BRPI0611729A2 (enExample)
CA (1) CA2611416C (enExample)
ES (1) ES2319475B1 (enExample)
MX (1) MX2007015528A (enExample)
NO (1) NO20080103L (enExample)
WO (1) WO2006131586A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331202A1 (de) 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
AU2007229603A1 (en) * 2006-03-24 2007-10-04 Unilever Plc Healthy food product
DE102006036285A1 (de) * 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
EP2253324A1 (en) * 2009-04-30 2010-11-24 Consejo Superior De Investigaciones Cientificas Use of a casein-derived peptide and compositions thereof as antihypertensive
CA2790996A1 (en) * 2010-02-24 2011-09-01 Morinaga Milk Industry Co. Ltd. Therapeutic agent for eating disorders
CN103232526B (zh) * 2012-12-12 2015-06-24 上海交通大学 一种生物活性多肽lplp及其制备和应用
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
CN103616454B (zh) * 2013-12-06 2015-06-03 贝因美婴童食品股份有限公司 一种定量检测人β-酪蛋白含量的方法以及试剂盒
CN104073539B (zh) * 2014-06-17 2017-03-29 黑龙江省乳品工业技术开发中心 一种牛乳β‑酪蛋白多元活性肽的制备方法及其应用
JP2017048124A (ja) * 2015-08-31 2017-03-09 森永乳業株式会社 アミノペプチダーゼａ阻害剤
EP3170507B1 (en) 2015-11-20 2022-12-21 Consejo Superior de Investigaciones Científicas (CSIC) Antihypertensive peptides from olive oil
CN107337710A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物
CN107814838A (zh) * 2017-12-07 2018-03-20 浙江辉肽生命健康科技有限公司 一种生物活性多肽ypqrdmpiqaf及其制备方法和应用
CN107880106B (zh) * 2017-12-11 2020-06-16 浙江辉肽生命健康科技有限公司 一种生物活性多肽vpitptlnre及其制备方法和应用
KR102073824B1 (ko) * 2018-04-11 2020-02-05 강원대학교산학협력단 간 보호용 건강기능식품 및 이의 제조 방법
CN111574585B (zh) * 2019-01-30 2021-10-01 浙江省医学科学院 一种鳕鱼皮寡肽及其分离纯化方法和应用
CN110498833B (zh) * 2019-08-30 2021-01-15 华南理工大学 一种具有ace抑制作用的三肽及其应用
US12359212B2 (en) 2019-11-22 2025-07-15 Mozza Foods, Inc. Recombinant micelle and method of in vivo assembly
US11326176B2 (en) 2019-11-22 2022-05-10 Mozza Foods, Inc. Recombinant micelle and method of in vivo assembly
CN111777665B (zh) * 2020-07-24 2022-07-05 北京林业大学 一种核桃粕抗氧化肽faw及其制备方法与应用
CN115505025A (zh) * 2022-11-10 2022-12-23 东北农业大学 一种基于老年人静态消化模型的乳清蛋白源抗氧化肽的筛选
CN116444619B (zh) * 2022-11-30 2024-07-16 内蒙古伊利实业集团股份有限公司 乳源活性肽ypfpgpihnslp及其制备方法与应用
CN116444608B (zh) * 2022-11-30 2024-06-25 内蒙古伊利实业集团股份有限公司 乳源活性肽dpsffake及其制备方法与应用
CN116444609B (zh) * 2022-11-30 2024-06-04 内蒙古伊利实业集团股份有限公司 乳源活性肽lppplpsrwpl及其制备方法与应用
CN118005726A (zh) * 2024-01-31 2024-05-10 上海交通大学 一种来源于驼奶的生物活性肽wpeylkt及其制备方法和应用
CN119170106B (zh) * 2024-11-20 2025-02-11 中国农业大学 一种马乳乳清蛋白源抗氧化肽筛选和制备方法及其应用
CN122036879A (zh) * 2024-11-22 2026-05-15 贵阳学院 一种乳源广谱抗菌肽w-1及其应用
CN121471310A (zh) * 2026-01-07 2026-02-06 深圳保时健生物工程有限公司 一种促骨骼生长牛奶蛋白肽及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444753C2 (de) 1994-12-15 1998-08-06 Forssmann Wolf Georg Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung
US6060448A (en) * 1995-10-31 2000-05-09 Pepsyn Limited Casein fragments having growth promoting activity
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
JP2002532383A (ja) * 1998-09-15 2002-10-02 ニゾ フード リサーチ 生物学的液体からペプチドを製造する方法及びその方法で得られるペプチド
US6514941B1 (en) 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
WO2003018606A2 (en) * 2001-08-30 2003-03-06 Chay 13 Medical Research Group N.V. Casein derived peptides and uses thereof in therapy
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
JP2004519204A (ja) 2000-05-08 2004-07-02 ダビスコ フーズ インターナショナル インコーポレーテッド 抗高血圧ペプチドの生成のための乳漿タンパク質の酵素処理、得られた産物、および哺乳動物における高血圧の処置
GB0016189D0 (en) * 2000-06-30 2000-08-23 Pepsyn Ltd Cosmetic composition
US6465432B1 (en) * 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
US7309491B2 (en) * 2003-04-11 2007-12-18 Antigenics Inc. Heat shock protein-based vaccines and immunotherapies
WO2004089986A1 (en) 2003-04-14 2004-10-21 Stichting Voor De Technische Wetenschappen Antimicrobial peptide from transferrin family

Also Published As

Publication number Publication date
BRPI0611729A2 (pt) 2010-10-05
EP2495250A3 (en) 2013-07-10
JP2008545774A (ja) 2008-12-18
KR101343904B1 (ko) 2013-12-23
US8354502B2 (en) 2013-01-15
EP2495250A2 (en) 2012-09-05
ES2319475A1 (es) 2009-05-07
US20100048464A1 (en) 2010-02-25
CA2611416C (en) 2015-10-06
ES2319475B1 (es) 2010-02-16
WO2006131586A1 (es) 2006-12-14
CA2611416A1 (en) 2006-12-14
WO2006131586B1 (es) 2007-02-01
CN103254278B (zh) 2015-07-22
AU2006256720A1 (en) 2006-12-14
CN103254278A (zh) 2013-08-21
EP1905779A1 (en) 2008-04-02
EP1905779A4 (en) 2010-09-01
MX2007015528A (es) 2008-02-25
NO20080103L (no) 2008-03-04
CN101305017A (zh) 2008-11-12
KR20080045108A (ko) 2008-05-22

Similar Documents

Publication Publication Date Title
CN103254278B (zh) 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法
Sharma et al. Bioactive peptides: a review
Sánchez et al. Bioactive peptides: A review
Muro Urista et al. Production and functionality of active peptides from milk
Kamau et al. Alpha‐lactalbumin: Its production technologies and bioactive peptides
EP1661913B1 (en) Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
Hernández-Ledesma et al. Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas
Korhonen et al. Bioactive peptides from food proteins
El-Sayed et al. Milk bioactive peptides: antioxidant, antimicrobial and anti-diabetic activities
Srinivas et al. Bioactive peptides from bovine milk α-casein: isolation, characterization and multifunctional properties
WO2010125192A1 (en) Use of a casein-derived peptide and compositions thereof as antihypertensive
Darewicz et al. The preventive potential of milk and colostrum proteins and protein fragments
María Hebert et al. Bioactive peptides derived from casein and whey proteins
Matar et al. Bioactive peptides from fermented foods: their role in the immune system
Chaudhari et al. Production and Biofunctionality of Milk-Derived Bioactive Peptides
Abbasi et al. Microbial Sources for Bioactive Peptides Conferring Health Benefits
Murthy et al. Casein-Derived Bioactive Peptides: Isolation, Characterization, and Functional Aspects
Recio et al. Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same.
Mandal et al. Whey Protein Derived Bioactive Peptides: Isolation, Characterization, and Functional Aspects
TWI412372B (zh) 心衰竭預防劑
Krishnaswami et al. Role of Milk-Derived Antimicrobial Peptides and their Future Perspectives in Pharmaceutical/Dairy Industries
Tech CHAUDHARI HIRALBEN MANSINHBHAI
Ranvir et al. Based Biofunctional Aspects
Salvado A comparative study between the correlation of the in silico and in vitro hydrolysis of whey proteins
Massoud et al. HEALTH-PROMOTING EFFECTS OF BIOACTIVE PEPTIDES IN MILK

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140806

Termination date: 20160608

CF01 Termination of patent right due to non-payment of annual fee